CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 811 - 820 of 828
Study Number Lead Group Study Title CIRB Study Status
WF-10217 NCORP-Wake Forest University Work Ability in Young Adult Survivors (WAYS) Cancer Prevention and Control CIRB Available to Open
NRG-CC004 NRG Phase II Double Blind Dose Finding Trial of Bupropion Versus Placebo for Sexual Desire In Women With Breast or Gynecologic Cancer Cancer Prevention and Control CIRB Available to Open
WF-1806 NCORP-Wake Forest University Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults with Colorectal Cancer: The M&M Study Cancer Prevention and Control CIRB Available to Open
A221405 Alliance A Study Evaluating the Pregnancy Outcomes and Safety of Interrupting Endocrine Therapy for Young Women with Endocrine Responsive Breast Cancer who Desire Pregnancy Cancer Prevention and Control CIRB Available to Open
S1501 SWOG Prospective Evaluation of Carvedilol in Prevention of Cardiac Toxicity in Patients with Metastatic HER-2+ Breast Cancer; Phase III Cancer Prevention and Control CIRB Available to Open
WF-1801 NCORP-Wake Forest University A Single Arm, Pilot Study of Ramipril for Preventing Radiation-Induced Cognitive Decline in Glioblastoma (GBM) Patients Receiving Brain Radiotherapy Cancer Prevention and Control CIRB Available to Open
A221701 Alliance Phase III Placebo-Controlled Trial to Evaluate Dexamethasone Use for Everolimus-Induced Oral Stomatitis: Prevention Versus Early Treatment Approaches Cancer Prevention and Control CIRB Available to Open
WF-1804CD NCORP-Wake Forest University Assessing effectiveness and implementation of an EHR tool to assess heart health among survivors (AH-HA) Cancer Prevention and Control CIRB Available to Open
UWI2016-07-01 CLO-University of Wisconsin Phase IIB Randomized, Placebo-Controlled Trial of ACTOplus met® XR in Subjects with Stage I-IV Squamous Cell Carcinoma of the Oral Cavity or Oropharynx Prior to Definitive Treatment Cancer Prevention and Control CIRB Available to Open
URCC-16070 NCORP-University of Rochester Cancer Center Treatment of Refractory Nausea Cancer Prevention and Control CIRB Available to Open
Displaying 811 - 820 of 828